Linsgliptin
Generic Name: linsgliptin
Dosage form: TABLET. Active ingredients: LINAGLIPTIN (5 mg/5mg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: TABLET. Active ingredients: LINAGLIPTIN (5 mg/5mg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as tablet.
Related Medications
Arnica Montana, Baryta Carbonica, Calcarea Phosphorica, Ginkgo Biloba, Hamamelis Virginiana, Millefolium, Phosphoricum Acidum
arnica montana, baryta carbonica, calcarea phosphorica, ginkgo biloba, hamamelis virginiana, millefolium, phosphoricum acidum
Dosage form: LIQUID. Active ingredients: ACHILLEA MILLEFOLIUM WHOLE (4 [hp_X]/mL); ARNICA MONTANA WHOLE (4 [hp_X]/mL); BARIUM CARBONATE (30 [hp_C]/mL); GINKGO (6 [hp_X]/mL); HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK (4 [hp_X]/mL); PHOSPHORIC ACID (30 [hp_C]/mL); TRIBASIC CALCIUM PHOSPHATE (30 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Octopamine
octopamine
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Sulfaphenazole
sulfaphenazole
Manufactured by PURDUE FREDERICK. Dosage form: TABLET. Route: ORAL. Active ingredients: SULFAPHENAZOLE (500MG). Application: NDA013092.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.